These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 22070014)

  • 1. [Neoadjuvant chemoradiotherapy of rectal carcinoma with bevacizumab].
    Slampa P
    Klin Onkol; 2011; 24(5):338-42. PubMed ID: 22070014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case report of pathologically complete response of locally advanced rectal cancer after neoadjuvant chemoradiotherapy with XELOX and bevacizumab].
    Miyazawa T; Ebe K; Fujita N; Koide N; Honma K; Ikarashi T
    Gan To Kagaku Ryoho; 2012 Jun; 39(6):1001-3. PubMed ID: 22705702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Possibilities of resistance prediction to neoadjuvant concomitant chemoradiotherapy in the treatment algorithm of patients with rectal carcinoma].
    Garajová I; Svoboda M; Slabý O; Kocáková I; Fabian P; Kocák I; Vyzula R
    Klin Onkol; 2008; 21(6):330-7. PubMed ID: 19382596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of modified OPTIMOX1 plus bevacizumab as the neoadjuvant therapy for highly advanced rectal cancers].
    Hirano A; Koda K; Suzuki M; Yamazaki M; Tezuka T; Kosugi C; Imai K; Nakagawa R; Adachi K; Shiragami R; Yasuda H
    Gan To Kagaku Ryoho; 2012 Jul; 39(7):1087-91. PubMed ID: 22790044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Research progress on pathologic complete response after neoadjuvant chemoradiotherapy for locally advanced rectal cancer].
    Peng HH; You KY; Gao YH; Wen BX
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Jun; 16(6):592-6. PubMed ID: 23801217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T3+ and T4 rectal cancer patients seem to benefit from the addition of oxaliplatin to the neoadjuvant chemoradiation regimen.
    Martijnse IS; Dudink RL; Kusters M; Vermeer TA; West NP; Nieuwenhuijzen GA; van Lijnschoten I; Martijn H; Creemers GJ; Lemmens VE; van de Velde CJ; Sebag-Montefiore D; Glynne-Jones R; Quirke P; Rutten HJ
    Ann Surg Oncol; 2012 Feb; 19(2):392-401. PubMed ID: 21792506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant chemoradiotherapy with capecitabine followed by laparoscopic resection in locally advanced tumors of middle and low rectum - toxicity and complications of the treatment.
    Soumarova R; Skrovina M; Bartos J; Gruna J; Wendrinski A; Czudek S; Kycina R; Parvez J
    Eur J Surg Oncol; 2010 Mar; 36(3):251-6. PubMed ID: 19879716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case report of successful treatment for rectosigmoid cancer with peritoneal dissemination after neoadjuvant chemoradiotherapy with XELOX and bevacizumab].
    Ishida M; Miyazawa T; Ebe K; Koide N; Fujita N; Honma K; Ikarashi T
    Gan To Kagaku Ryoho; 2013 Jan; 40(1):103-5. PubMed ID: 23306929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short term results of neoadjuvant chemoradiotherapy with fluoropyrimidine alone or in combination with oxaliplatin in locally advanced rectal cancer: a meta analysis.
    An X; Lin X; Wang FH; Goodman K; Cai PQ; Kong LH; Fang YJ; Gao YH; Lin JZ; Wan DS; Pan ZZ; Ding PR
    Eur J Cancer; 2013 Mar; 49(4):843-51. PubMed ID: 23063351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy, safety, and biomarkers of neoadjuvant bevacizumab, radiation therapy, and fluorouracil in rectal cancer: a multidisciplinary phase II study.
    Willett CG; Duda DG; di Tomaso E; Boucher Y; Ancukiewicz M; Sahani DV; Lahdenranta J; Chung DC; Fischman AJ; Lauwers GY; Shellito P; Czito BG; Wong TZ; Paulson E; Poleski M; Vujaskovic Z; Bentley R; Chen HX; Clark JW; Jain RK
    J Clin Oncol; 2009 Jun; 27(18):3020-6. PubMed ID: 19470921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A simplified tumor regression grade correlates with survival in locally advanced rectal carcinoma treated with neoadjuvant chemoradiotherapy.
    Beddy D; Hyland JM; Winter DC; Lim C; White A; Moriarty M; Armstrong J; Fennelly D; Gibbons D; Sheahan K
    Ann Surg Oncol; 2008 Dec; 15(12):3471-7. PubMed ID: 18846402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective feasibility study to evaluate neoadjuvant-synchronous S-1 + RT for locally advanced rectal cancer: a multicenter phase II trial (UMIN ID: 03396).
    Inomata M; Akagi T; Nakajima K; Etoh T; Shiraishi N; Tahara K; Matsumoto T; Kinoshita T; Fujii K; Shiromizu A; Kubo N; Kitano S
    Jpn J Clin Oncol; 2013 Mar; 43(3):321-3. PubMed ID: 23275647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of interval between neoadjuvant chemoradiotherapy and TME for locally advanced rectal cancer on pathologic response and oncologic outcome.
    Wolthuis AM; Penninckx F; Haustermans K; De Hertogh G; Fieuws S; Van Cutsem E; D'Hoore A
    Ann Surg Oncol; 2012 Sep; 19(9):2833-41. PubMed ID: 22451236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II trial of neoadjuvant chemotherapy with XELOX plus bevacizumab for locally advanced rectal cancer.
    Uehara K; Ishiguro S; Sakamoto E; Maeda A; Inoue M; Tojima Y; Kobayashi S; Omiya N; Ishizuka N; Nakao A; Goto H; Nagino M
    Jpn J Clin Oncol; 2011 Aug; 41(8):1041-4. PubMed ID: 21803876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preoperative chemoradiotherapy as neoadjuvant therapy for 35 patients with locally advanced lower rectal carcinoma].
    Feng HY; Li DC; Lou RC; Zhu Y; Liu LY
    Zhonghua Wei Chang Wai Ke Za Zhi; 2005 Mar; 8(2):125-8. PubMed ID: 16155821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defined, locally advanced rectal cancer: Grupo cancer de recto 3 study.
    Fernández-Martos C; Pericay C; Aparicio J; Salud A; Safont M; Massuti B; Vera R; Escudero P; Maurel J; Marcuello E; Mengual JL; Saigi E; Estevan R; Mira M; Polo S; Hernandez A; Gallen M; Arias F; Serra J; Alonso V
    J Clin Oncol; 2010 Feb; 28(5):859-65. PubMed ID: 20065174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase II study of neoadjuvant chemoradiotherapy with oxaliplatin and capecitabine for rectal cancer.
    Zhao L; Bai C; Shao Y; Guan M; Jia N; Xiao Y; Qiu H; Zhang F; Yang T; Zhong G; Chen S
    Cancer Lett; 2011 Nov; 310(2):134-9. PubMed ID: 21782322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinically-staged T3N0 rectal cancer: is preoperative chemoradiotherapy the optimal treatment?
    Lombardi R; Cuicchi D; Pinto C; Di Fabio F; Iacopino B; Neri S; Tardio ML; Ceccarelli C; Lecce F; Ugolini G; Pini S; Di Tullio P; Taffurelli M; Minni F; Martoni A; Cola B
    Ann Surg Oncol; 2010 Mar; 17(3):838-45. PubMed ID: 20012700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic and predictive value of baseline and posttreatment molecular marker expression in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.
    Bertolini F; Bengala C; Losi L; Pagano M; Iachetta F; Dealis C; Jovic G; Depenni R; Zironi S; Falchi AM; Luppi G; Conte PF
    Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1455-61. PubMed ID: 17445998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Timing of surgery after neoadjuvant long-course chemoradiotherapy in the management of locally advanced rectal cancer.
    Panagiotopoulou IG; Parashar D; Mezher-Sikafi R; Parmar J; Wells AD; Menon M; Jephcott CR
    Clin Oncol (R Coll Radiol); 2012 Dec; 24(10):e195. PubMed ID: 22999843
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.